What caused the MDG1.DE stock drop pre-market on 16 Jan 2026?

The pre-market drop to **€0.1335** was driven by heavy selling and high volume. No single public catalyst was posted; liquidity and technical selling amplified declines. Clinical or funding news could follow, so watch official releases.

Is MDG1.DE stock a buy on this oversold bounce?

An oversold bounce can offer short-term gains, but fundamentals are weak. Use small sizes, short stops, and targets like **€0.25**. This is a speculative trade, not a long-term buy recommendation.

What are key levels to watch for MDG1.DE stock today?

Watch intraday support near **€0.08**, initial resistance at **€0.16**, and secondary resistance around **€0.25**. Volume confirmation above average improves bounce odds.

How does Meyka AI rate MDG1.DE stock?

Meyka AI rates MDG1.DE with a score of **57.97/100** (Grade **C+**, Suggestion: **HOLD**). The grade factors sector, growth, metrics, and consensus and is informational only.

DE Stocks

MDG1.DE Medigene AG (XETRA) -27% pre-market 16 Jan 2026: Oversold bounce watch

ByHuzaifa Zahoor January 16, 2026January 16, 2026

MDG1.DE stock plunged in pre-market trade on 16 Jan 2026, trading at €0.1335 after a -27.64% intraday move. The sharp drop came with volume at 189,470 shares, well above the 50-day average. For short-term traders using an oversold-bounce strategy, the gap and heavy volume set up a clear mean-reversion test and defined levels to watch on XETRA in Germany.